CD274 and neoplasm: Anaphylactic reactions have been reported with PD-L1 and PD1 monoclonal antibodies in the orthotropic 4T1 tumor model [30] (Mall et al., [31]), thus, for these studies we utilized the CT26 mouse model well known to be responsive to various degrees to PD-1 axis immunotherapy [32].